No Comments

Sanofi turns to subscriptions to offer patients insulin at $99 per month

In the latest move by a drugmaker to address insulin pricing criticism, Sanofi is rolling out a subscription model to allow patients access for $99 per month.

Read full article here:

You might also like
Share this article